CME vs. STT: A Head-to-Head Stock Comparison

Updated on August 19, 2025

Here’s a clear look at CME and STT, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Symbol	CME	STT
Company Name	CME Group Inc.	State Street Corporation
Country	United States	United States
GICS Sector	Financials	Financials
GICS Industry	Capital Markets	Capital Markets
Market Capitalization	98.72 billion USD	31.63 billion USD
Exchange	NasdaqGS	NYSE
Listing Date	December 6, 2002	March 17, 1980
Security Type	Common Stock	Common Stock

Historical Performance

This chart compares the performance of CME and STT by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CME vs. STT: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	CME	STT
5-Day Price Return	-2.50%	1.53%
13-Week Price Return	1.28%	16.15%
26-Week Price Return	12.07%	11.96%
52-Week Price Return	32.59%	43.82%
Month-to-Date Return	-1.57%	-0.22%
Year-to-Date Return	17.95%	13.60%
10-Day Avg. Volume	1.98M	1.56M
3-Month Avg. Volume	2.45M	2.12M
3-Month Volatility	20.30%	24.02%
Beta	0.43	1.51

Profitability

Return on Equity (TTM)

CME

13.77%

Capital Markets Industry

Max: 38.97%
Q3: 21.61%
Median: 13.77%
Q1: 8.31%
Min: -4.25%

CME’s Return on Equity of 13.77% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

STT

10.85%

Capital Markets Industry

Max: 38.97%
Q3: 21.61%
Median: 13.77%
Q1: 8.31%
Min: -4.25%

STT’s Return on Equity of 10.85% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

CME vs. STT: A comparison of their Return on Equity (TTM) against the Capital Markets industry benchmark.

Net Profit Margin (TTM)

CME

34.84%

Capital Markets Industry

Max: 66.67%
Q3: 35.11%
Median: 23.49%
Q1: 13.63%
Min: -15.18%

CME’s Net Profit Margin of 34.84% is aligned with the median group of its peers in the Capital Markets industry. This indicates its ability to convert revenue into profit is typical for the sector.

STT

20.50%

Capital Markets Industry

Max: 66.67%
Q3: 35.11%
Median: 23.49%
Q1: 13.63%
Min: -15.18%

STT’s Net Profit Margin of 20.50% is aligned with the median group of its peers in the Capital Markets industry. This indicates its ability to convert revenue into profit is typical for the sector.

CME vs. STT: A comparison of their Net Profit Margin (TTM) against the Capital Markets industry benchmark.

Operating Profit Margin (TTM)

CME

79.34%

Capital Markets Industry

Max: 86.40%
Q3: 46.46%
Median: 32.80%
Q1: 18.32%
Min: -21.87%

An Operating Profit Margin of 79.34% places CME in the upper quartile for the Capital Markets industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

STT

24.96%

Capital Markets Industry

Max: 86.40%
Q3: 46.46%
Median: 32.80%
Q1: 18.32%
Min: -21.87%

STT’s Operating Profit Margin of 24.96% is around the midpoint for the Capital Markets industry, indicating that its efficiency in managing core business operations is typical for the sector.

CME vs. STT: A comparison of their Operating Profit Margin (TTM) against the Capital Markets industry benchmark.

Profitability at a Glance

Symbol	CME	STT
Return on Equity (TTM)	13.77%	10.85%
Return on Assets (TTM)	2.46%	0.79%
Net Profit Margin (TTM)	34.84%	20.50%
Operating Profit Margin (TTM)	79.34%	24.96%
Gross Profit Margin (TTM)	95.97%	--

Financial Strength

Current Ratio (MRQ)

CME

1.02

Capital Markets Industry

Max: 3.76
Q3: 1.89
Median: 1.01
Q1: 0.54
Min: -0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

STT

Capital Markets Industry

Max: 3.76
Q3: 1.89
Median: 1.01
Q1: 0.54
Min: -0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

CME vs. STT: A comparison of their Current Ratio (MRQ) against the Capital Markets industry benchmark.

Debt-to-Equity Ratio (MRQ)

CME

0.12

Capital Markets Industry

Max: 6.62
Q3: 2.84
Median: 1.02
Q1: 0.32
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

STT

1.40

Capital Markets Industry

Max: 6.62
Q3: 2.84
Median: 1.02
Q1: 0.32
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

CME vs. STT: A comparison of their Debt-to-Equity Ratio (MRQ) against the Capital Markets industry benchmark.

Interest Coverage Ratio (TTM)

CME

2,242.33

Capital Markets Industry

Max: 126.03
Q3: 60.98
Median: 11.77
Q1: 4.95
Min: -36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

STT

Capital Markets Industry

Max: 126.03
Q3: 60.98
Median: 11.77
Q1: 4.95
Min: -36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

CME vs. STT: A comparison of their Interest Coverage Ratio (TTM) against the Capital Markets industry benchmark.

Financial Strength at a Glance

Symbol	CME	STT
Current Ratio (MRQ)	1.02	--
Quick Ratio (MRQ)	1.02	--
Debt-to-Equity Ratio (MRQ)	0.12	1.40
Interest Coverage Ratio (TTM)	2,242.33	--

Growth

Revenue Growth

CME vs. STT: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CME vs. STT: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CME

3.92%

Capital Markets Industry

Max: 10.26%
Q3: 4.86%
Median: 2.78%
Q1: 1.22%
Min: 0.00%

CME’s Dividend Yield of 3.92% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

STT

3.38%

Capital Markets Industry

Max: 10.26%
Q3: 4.86%
Median: 2.78%
Q1: 1.22%
Min: 0.00%

STT’s Dividend Yield of 3.38% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

CME vs. STT: A comparison of their Dividend Yield (TTM) against the Capital Markets industry benchmark.

Dividend Payout Ratio (TTM)

CME

102.42%

Capital Markets Industry

Max: 200.72%
Q3: 101.92%
Median: 57.97%
Q1: 32.36%
Min: 0.00%

CME’s Dividend Payout Ratio of 102.42% is in the upper quartile for the Capital Markets industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.

STT

37.74%

Capital Markets Industry

Max: 200.72%
Q3: 101.92%
Median: 57.97%
Q1: 32.36%
Min: 0.00%

STT’s Dividend Payout Ratio of 37.74% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

CME vs. STT: A comparison of their Dividend Payout Ratio (TTM) against the Capital Markets industry benchmark.

Dividend at a Glance

Symbol	CME	STT
Dividend Yield (TTM)	3.92%	3.38%
Dividend Payout Ratio (TTM)	102.42%	37.74%

Valuation

Price-to-Earnings Ratio (TTM)

CME

26.14

Capital Markets Industry

Max: 58.89
Q3: 31.00
Median: 18.54
Q1: 12.09
Min: 5.24

CME’s P/E Ratio of 26.14 is within the middle range for the Capital Markets industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

STT

11.18

Capital Markets Industry

Max: 58.89
Q3: 31.00
Median: 18.54
Q1: 12.09
Min: 5.24

In the lower quartile for the Capital Markets industry, STT’s P/E Ratio of 11.18 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

CME vs. STT: A comparison of their Price-to-Earnings Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Sales Ratio (TTM)

CME

9.11

Capital Markets Industry

Max: 14.49
Q3: 7.41
Median: 4.68
Q1: 2.25
Min: 0.04

CME’s P/S Ratio of 9.11 is in the upper echelon for the Capital Markets industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

STT

1.80

Capital Markets Industry

Max: 14.49
Q3: 7.41
Median: 4.68
Q1: 2.25
Min: 0.04

In the lower quartile for the Capital Markets industry, STT’s P/S Ratio of 1.80 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

CME vs. STT: A comparison of their Price-to-Sales Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Book Ratio (MRQ)

CME

3.58

Capital Markets Industry

Max: 9.48
Q3: 4.94
Median: 2.42
Q1: 1.21
Min: 0.38

CME’s P/B Ratio of 3.58 is within the conventional range for the Capital Markets industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

STT

1.11

Capital Markets Industry

Max: 9.48
Q3: 4.94
Median: 2.42
Q1: 1.21
Min: 0.38

STT’s P/B Ratio of 1.11 is in the lower quartile for the Capital Markets industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

CME vs. STT: A comparison of their Price-to-Book Ratio (MRQ) against the Capital Markets industry benchmark.

Valuation at a Glance

Symbol	CME	STT
Price-to-Earnings Ratio (TTM)	26.14	11.18
Price-to-Sales Ratio (TTM)	9.11	1.80
Price-to-Book Ratio (MRQ)	3.58	1.11
Price-to-Free Cash Flow Ratio (TTM)	23.98	6.86